Evidence mapPaperPMID 38159172Full record

SynthesisEndocrine2024

Global prevalence of hypomagnesemia in type 2 diabetes mellitus - a comprehensive systematic review and meta-analysis of observational studies.

Aakanksha Pitliya, Srivatsa Surya Vasudevan, Vanshika Batra, Mizba Basheer Patel, Anjali Desai, Sanjana Nethagani, Anmol Pitliya

Abstract readSystematic ReviewMeta-Analysis
PubMed Publisher
In one paragraph

Synthesis in Endocrine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Magnesium Level and Related Factors in Type 2 Diabetes Mellitus: A Cross-Sectional StudyEndocrine, metabolic & immune disorders drug targets · 2026
    Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Aakanksha PitliyaPamnani Hospital and Research Center, (Department of Medicine), Mandsaur, Madhya Pradesh, India.
Srivatsa Surya VasudevanMayo Clinic, (Department of Otolaryngology - Head and Neck Surgery), Jacksonville, FL, USA. Srivatsa.Suryavasudevan@gmail.com.ORCID 0000-0002-6998-1658
Vanshika BatraSGT Medical College, (Student), Gurugram, Haryana, India.
Mizba Basheer PatelMRV Clinic, (Junior Physician), Hyderabad, Telangana, India.
Anjali DesaiSurat Municipal Institute of Medical Education and Research, (Department of Medicine), Surat, Gujarat, India.
Sanjana NethaganiCamden Clark Medical Center/University of West Virginia, (Resident Physician, Department of Internal Medicine), Parkersburg, WV, USA.
Anmol PitliyaCamden Clark Medical Center/University of West Virginia, (Hospitalist, Department of Internal Medicine), Parkersburg, WV, USA.
Ark Medical Center · USHyderabad Rheumatology Center · INJacksonville College · USSardar Vallabhbhai National Institute of Technology Surat · INShree Guru Gobind Singh Tricentenary University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeHypomagnesemia, characterized by low magnesium levels, has been implicated in the pathophysiology of Type 2 Diabetes Mellitus (T2DM). This meta-analysis aims to provide a comprehensive assessment of hypomagnesemia prevalence in individuals with T2DM as well as its potential implications for diabetes management and complications.

methodsWe conducted a comprehensive systematic review and meta-analysis using databases like PubMed, Google Scholar, Science Direct, and Research Gate to identify relevant studies between January 2008 and August 2023. We focused on observational studies related to serum magnesium levels and Type 2 Diabetes in individuals aged 19 and older. Newcastle Ottawa tool was used for quality assessment. A random effect meta-analysis was performed to calculate the prevalence of hypomagnesemia in T2DM.

resultsWe identified a total of 671 studies, and after screening 383 abstracts and full texts by two independent reviewers, we identified 19 eligible studies encompassing 4192 patients diagnosed with T2DM. The mean age was 55.4 (SD, 4.39) years with a mean HbA1C level of 8.01. The pooled prevalence of hypomagnesemia in T2DM was 32% (95% CI: 22-36%) out of 4192 cases. On subgroup analysis, the prevalence of hypomagnesemia in male and female were 19.8% and 20.1%, respectively. Geographically, Asia had the highest prevalence of hypomagnesemia with 31.9% (95% CI: 24-41.1%).

conclusionThis meta-analysis highlights a significant prevalence of hypomagnesemia in individuals with T2DM, emphasizing the need for further investigation due to the intricate nature of the association between serum magnesium levels and T2DM.

Indexed as

Diabetes Mellitus, Type 2MagnesiumMagnesium DeficiencyObservational Studies as TopicFemaleGlobal HealthHumansMaleMiddle AgedPrevalenceMagnesiumHypomagnesemiaInsulin resistanceMeta-analysisPrevalenceT2DMType 2 diabetes mellitus

Identifiers

PMID38159172
OpenAlexW4390445859

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.